Thermo Fisher Webinars
-
Leveraging dPCR r Techniques To Quantitate Lentivirus Particles
5/28/2025
Discover how digital PCR can streamline lentiviral vector characterization to reduce variability and improve analytical sensitivity. Learn how this approach can help you comply with regulatory guidance.
-
Scalable Production Of Lentivirus For Research To Commercial Manufacturing
10/30/2024
Join our webinar on scaling the CTS LV-MAX System in bioreactors, covering transfection scalability, Thermo S.U.B. advantages, and DynaSpin’s efficient gene therapy integration.
-
AAV Purification: Solving Downstream Challenges
6/9/2025
In this roundtable discussion, a trio of distinguished experts in AAV purification and process development share their expertise and best practices in tackling and solving downstream challenges.
-
Supporting Development Of mRNA Therapeutics By Enabling Commercial-Scale mRNA Purification
6/9/2025
Discover the next generation of scalable affinity capture for high-quality mRNA purification. Learn how a simple, reliable binding mechanism can maximize efficiency and simplify your manufacturing process.
-
Next-Gen Disease Models And Cell Therapeutics: Innovations In AI, Omics And Collaboration
8/20/2025
Learn how to leverage AI, omics integration, and collaborative research to build more physiologically relevant disease models and accelerate the development of next-gen cell therapies.
-
Digital Design Meets Proven Performance: The Future Of Single-Use Assemblies
3/31/2026
Single-use assembly design is evolving fast. Learn how scalable platforms, digital automation tools, and global supply networks are converging to support sustainable biopharma manufacturing at scale.
-
Advancing The Purification Of VSV-G Pseudotyped Lentiviral Vector
6/9/2025
Discover new strategies to overcome lentiviral purification challenges with a scalable approach that maintains viral infectivity through gentle processing conditions.
-
Efficient Scale-Up Of Monoclonal Antibody Production: From Bench Top To 500L
8/11/2025
Scaling monoclonal antibody production from the lab to a commercial scale can be challenging. Learn about an approach that helps you maintain consistent productivity and product quality across all scales.
-
Defined Media, Defined Results: Scaling E. coli From Bench To Fermenter
4/9/2026
Understand the benefits of chemically defined media in E. coli systems, explore real-world plasmid DNA data, and learn practical strategies for scaling to robust manufacturing.
-
Advancing Vaccine Development With Novel Chromatography Solutions & Quality Testing
6/24/2025
Learn more on novel chromatography solutions that can help improve the downstream processes of different vaccine types such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs).